Shimoli Shah Shimoli Shah Watch how Shimoli transitioned from practising clinician to Patient Safety Physician.
CHMP_opinion_nintedanib_ILD_PF CHMP_opinion_nintedanib_ILD_PF Nintedanib received a CHMP positive opinion for the treatment of patients with other chronic fibrosing ILDs with a progressive phenotype beyond IPF
Taking cancer on together Taking cancer on together Through their work, our colleagues from around the world hope to empower patients to Take Cancer On.
EC_approval_nintedanib_ILD_PF EC_approval_nintedanib_ILD_PF European Commission approves nintedanib for the treatment of patients with other chronic fibrosing ILDs with a progressive phenotype beyond IPF
Translational Medicine in Immunology Translational Medicine in Immunology Find out how translational medicine is helping bring transformational therapies to patients
Samina Ajaz Hussain Samina Ajaz Hussain Discover how Samina never looked back on her career move to Patient Safety.
EURORDIS Award EURORDIS Award EURORDIS has selected Boehringer Ingelheim for the first time as recipient of the prestigious Black Pearl Award 2020
From social worker to joining the pharmaceutical industry From social worker to joining the pharmaceutical industry Patient centricity: How Miyuki Ono contributes to our diverse workforce with her experience as a social worker and helps patients in Japan
Social innovation: catalyst for sustainable health solutions Social innovation: catalyst for sustainable health solutions Supporting social innovators drives sustainable health solutions in underserved communities. Learn more about Boehringer Ingelheim Social Engagements.
The Boehringer Ingelheim Veterinary Scholars Program The Boehringer Ingelheim Veterinary Scholars Program The aim of the Boehringer Ingelheim Veterinary Scholars Program is to expose students to biomedical research
BI_X_Shanghai BI_X_Shanghai Boehringer Ingelheim opens a second branch of its digital lab in Shanghai
Boehringer founding sponsor of CKM Health Initiative Boehringer founding sponsor of CKM Health Initiative Boehringer Ingelheim founding sponsor of AHA's Cardiovascular-Kidney-Metabolic Health Initiative
CHMP recommends conditional approval for first GPP treatment CHMP recommends conditional approval for first GPP treatment CHMP recommends conditional marketing authorization for novel IL-36 receptor monoclonal antibody, spesolimab, as first treatment for generalized pustular psoriasis flares
Earthquakes Türkiye & Syria Earthquakes Türkiye & Syria Support for those impacted by Türkiye & Syria earthquakes
Spotlight on GPP Spotlight on GPP Emmanuelle Clerisme-Beaty, former Head of Clinical Development and Medical Affairs, Dermatology, answers some frequently asked questions about GPP.
Bridging the gap in Generalized Pustular Psoriasis (GPP) Bridging the gap in Generalized Pustular Psoriasis (GPP) Emmanuelle Clerisme-Beaty, former Head of Clinical Development and Medical Affairs, Dermatology, discusses published insights from GPP patients.
Full data chronic kidney disease trial efficacy Full data chronic kidney disease trial efficacy Positive full data results announced from the EMPA-KIDNEY Phase III trial in adults with chronic kidney disease